Author Search Results

1

Neurological syndrome in an HIV-prevention trial participant randomized to daily tenofovir disoproxil fumarate (300 mg) and emtricitabine (200 mg) in Bondo, Kenya

by Owino F, Mandala J, Ambia J, Agot K, Van Damme L
Published 2013-11-01

Get full text

Article
2

Implementing good participatory practice guidelines in the FEM-PrEP Preexposure Prophylaxis Trial for HIV Prevention among African Women: a focus on local stakeholder involvement

by Mack N, Kirkendale S, Omullo P, Odhiambo J, Ratlhagana M, Masaki M, Siguntu P, Agot K, Ahmed K, Kapiga S, Lombaard J, Van Damme L, Corneli A
Published 2013-10-01

Get full text

Article
3

Lessons learnt from implementing an empirically informed recruitment approach for FEM-PrEP, a large HIV prevention clinical trial

by Parker C, Corneli A, Agot K, Odhiambo J, Asewe J, Ahmed K, Skhosana J, Ratlhagana M, Lanham M, Wong C, Deese J, Manongi R, Van Damme L
Published 2014-12-01

Get full text

Article
4

Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis

by Morrison, C.S, Chen, P.L, Kwok, C., Baeten, J.M, Brown, J., Crook, A., van Damme, L., Delany-Moretlwe, S., Francis, S.C, Friedland, B., Hayes, R.J, Heffron, R., Kapiga, S., Karim, Q., Kaul, R., McClelland, S., McCormack, S., McGrath, N., Myer, L., Rees, H., van der Straten, A., Watson-Jones, D., van de Wijgert, J.H, Stalter, R., Low, N.
Published 2015

Call Number: Loading...
Located: Loading...

Get fulltext

Article